MAPS staff members provide public comments to governmental bodies about proposed legislation or regulations concerning psychedelics during time periods prescribed by law.
Written by Rick Doblin, Ph.D, in collaboration with Ismail L. Ali, JD, and Natalie Lyla Ginsberg, M.S.W. | March 15, 2017
Public Comment Submitted to President’s Commission on Combating Drug Addiction and the Opioid Crisis | June 16, 2017